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Summary In this study we investigated whether intracerebroventricular (i.c.v.)
injection of L-NAME (a nitric oxide synthase inhibitor) or CaEDTA (an extracellular zinc
chelator) or the combination of the two could affect the initial phase of pilocarpine
induced (2 h) seizures. Two groups of rats were used. Animals from both groups were
given with i.c.v. injections of either saline (10 ml), L-NAME (150 mg/10 ml), CaEDTA
(100 mM/10 ml) or L-NAME and CaEDTA. One group received pilocarpine HCl (380 mg/
kg i.p.) the other served as control. Pilocarpine HCl was injected intraperitoneally
10 min later. The behavior of the animals was observed for 2 h and the intensity of
their seizures was scored. The rats were then sacrificed and their brains were removed
and analyzed for zinc ions by using the immersion autometallography and the TSQ
fluorescence staining.
All the animals which received pilocarpine HCl developed seizures. Despite
treatment with L-NAME and/or CaEDTA we found that the latency and the intensity
of seizures were similar in both groups investigated. The distribution of stainable zinc
ions and the intensity of staining in hippocampus were not affected by pilocarpine and
found unchanged after L-NAME and/or CaEDTA injections in both the control animals
and the pilocarpine treated animals. The data suggest that the nitric oxide system and
zinc ions do not affect pilocarpine-induced seizures in their initial state.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Nitric oxide (NO) is a free radical diffusible gas,which
is a potential neurotransmitter and retrograde mes-
senger molecule and is suggested to be involved in* Corresponding author. Tel.: +90 224 442 91 37;
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doi:10.1016/j.seizure.2007.02.012synaptic plasticity in the central nervous system.1 In
nerve cells NO is formed from L-arginine by the Ca2+/
calmoduline-dependent enzyme neuronal nitric
oxide synthase (nNOS). This enzyme cascade is acti-
vated mainly by the N-methyl-D-aspartate (NMDA)-
type glutamate receptors2 and the production of
NO is accordingly enhanced in conditions, such as
epilepsy, where synaptic release of glutamate
and neuronal depolarization promotes Ca2+ influx. Published by Elsevier Ltd. All rights reserved.
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enhanced production of NO during experimentally
induced seizures suggests that NO has a role in the
pathophysiology of epilepsy, but data on this issue are
contradictory.6 Treatment of pilocarpine induced
seizures with NOS inhibitors has been reported to
augment,7,8 to inhibit9,10 or to be without effects11
on the epileptic activity. An enhanced production of
NO may be a central element in the excitotoxic
neuronal damage which can be found after long
lasting chemically induced seizures. Neuronal
damage caused by NO appears to be linked to oxida-
tive stress and mitochondrial dysfunction, but other
factorsmaybe involved.12,13 Fredericksonetal.14 has
reported that NO induces a release of zinc ions from
mossy fibers boutons in the CA3 areas of the hippo-
campus and Cuajungco and Lees15 has shown that
treatment with NO generators is epileptogenic and
results in an increaseof theconcentrationofunbound
zinc ions in hippocampal pyramidal cells. Contrary,
intracellular zinc ions interferes with the production
of NO by potently inhibiting the nNOS activity.16,17
Most zinc ions in the mammalian brain are tightly
bound to metalloenzymes, but more loosely bound
zinc ions (about 8%) are found in synaptic vesicles in a
subset of the glutamatergic neurons in cerebrum.
Although the vesicular zinc is a small fraction of total
zinc in the brain, it is the only fraction of zinc that can
be traced histochemically. The Autometallography
(AMG) and N-(6-methoxy-8-quinolyl)-para-toluene-
sulfonamide (TSQ) detectable zinc is present as free
or loosely bound zinc ions in the synaptic vesicules of
some glutamatergic neurons.18—20 Vesicular zinc ions
are believed to be released during normal synaptic
transmission,18—20 but the amount of ions released
may be less than previously expected.21 Released
zinc ions may serve a role as endogenous neuromo-
dulator/neurotransmitter and may affect neuron
excitability by modulating excitatory and inhibitory
receptors, i.e. excite AMPA/KA receptor and inhibit
NMDA and GABAA receptors.22—24 Synaptically
released zinc ions could (like NO) contribute to the
excitotoxic neurodegenerative seen in relation to
seizures.22,25,26 It is hypothesized that zinc ions are
released fromzinccontaining vesicles and then trans-
located to postsynaptic neurons where it interferes
with the normal cellular metabolism.25 Recent inves-
tigation of mice lacking vesicular zinc caused by a
disruption of the gene encoding for the vesicular zinc
transporter ZnT327 has suggested that accumulation
of free intracellular zinc ions during seizures involves
other mechanisms, such as release of zinc from post-
synaptic zinc sequestering proteins and a mitochon-
drial pool.27—29
The hypothetical link between NO production and
the release of zinc ions during short lasting (2 h)seizures induced by pilocarpine have not previously
been investigated. We have therefore examined
whether or not NOS inhibition and/or chelation of
extracellular zinc ions would modulate the initial
phase of pilocarpine-induced seizures and/or
change the histochemical distribution of zinc ions
in hippocampus.Materials and methods
Animals
Male Sprague—Dawley rats (n = 60), 3 month old,
weighing 300—320 g, (Møllegaard Breeding Centre,
Ejby, Denmark) were used throughout the experi-
ments. Rats were housed in groups of four with ad
libitum access to food and water. Rats were main-
tained on a 12-h light:12-h dark schedule and at a
temperature of 21—22 8C. All experimental proce-
dures were conducted accordingly to NIH and EU
guidelines for care and use of animals.
Surgical procedure
All rats were equipped with permanent cannulas for
intracerebroventricular injection (i.c.v.) of 10 ml
saline or 10 ml saline containing the drug investi-
gated. The rats were anesthetized with isoflurane
(induction dose 3.5%, maintenance 3%). A burr hole
was drilled through the skull 1.5 mm lateral to the
midline and 1 mm posterior to bregma on the left
side. Through this hole, a 10 mm, length 20 gauge
stainless steel hypodermic tube was directed
toward the left lateral ventricle. The cannula was
lowered 4—4.2 mm below the surface of the skull
perpendicularly and was fixed to the skull with
acrylic cement. Following the surgical procedure,
the rats were placed individually in cages and
allowed to recover from the anesthesia for at least
4 h.
The drugs investigated and given as i.c.v. injec-
tions were saline, N-nitro-L-arginine methylester (L-
NAME) (150 mg) and/or ethylenediaminetetraaceti-
cacide-disodium-calcium salt (CaEDTA) (100 mM). L-
NAME, CaEDTA, pilocarpine HCl and methyl-scopo-
lamine were purchased from Sigma Chemical Co.
(St. Louis, MO).
The experimental groups in this study were:
Control groups
1. (n = 5), control group (saline injected group);
2. (n = 5), L-NAME injected group;
3. (n = 5), CaEDTA injected group;
4. (n = 5), L-NAME and CaEDTA injected group.Pilocarpine and drugs injected groups
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carpine HCl injected group);
6. (n = 10), L-NAME and pilocarpine HCl injected
group;
7. (n = 10), CaEDTA and pilocarpine HCl injected
group;
8. (n = 10), L-NAME and CaEDTA and pilocarpine HCl
injected group.A subset of the rats (n = 40) were given an intra-
peritoneal injection (i.p.) of pilocarpine HCl (380
mg/kg) in order to induce seizures. Pilocarpine HCl
was given 10 min after the i.c.v. injection of drugs.
Peripheral cholinergic side effects were reduced by a
methylscopolamine (1 mg/kg, subcutaneous)
injected 30 min before the injection of pilocarpine
HCl.
All rats were observed for 2 h after the injection
of pilocarpine HCl for behavioral signs of seizure
activity. Scoring was made according to the most
intense seizure that was witnessed during 2 h obser-
vation time. The time of the most intense seizure
was different at each animal. At the end of the 2-h
period rats were decapitated under the isoflurane
anesthesia. The brain was removed from the scull
and the left hemisphere was isolated and cut hor-
izontally into a ventral and a dorsal part used for
histological processing.
Behavioral evaluation of seizure activity
The Racine scale30 was used to evaluate the inten-
sity of the limbic seizures. The scores given to the
behavioral signs of seizures were as follows:0 point: immobility, no seizures;
1 point: facial automatisms;
2 point: head nodding;
3 point: unilateral or bilateral forelimb clonus;
4 point: bilateral forelimb clonus and rearing;
5 point: rearing, falling and generalized convul-
sions.Immersion autometallography (iZnSAMG)
This method is based on capturing of zinc ions, in the
sections or in blocks of tissue, as zinc sulphide
molecules that can be visualized light microscopi-
cally after AMG development. A 2 mm horizontally
slice was cut from the dorsal side of the left ventral
hemisphere. The slice containing a part of hippo-
campus were immersed in the NeoTimm solution,
i.e. 3% glutaraldehyde and 0.1% Na2S in a 0.1 M
Sorensen phosphate buffer, pH 7.4. The immersion
jars were placed on a shaker for 3 days at 4 8C. The
slices were carefully rinsed twice in 0.1 M phosphatebuffer for 10 min. Then cryoprotected, frozen on a
stage with CO2, gas, cut into 30 mm sections, and
placed on gelatin-coted glass slides. The glass slides
were placed in a jar and exposed to the AMG devel-
oper (60 ml gum Arabic/10 ml sodium citrate buf-
fer/15 ml hydroquinone/15 ml silver lactate) and
developed for 60 min at 26 8C. After a stop bath
(5% sodium thiosulfate for 10 min) and thorough
wash the sections were counterstained with Tolui-
dine blue, mounted in DEPEX and covered with a
coverglass.31
TSQ fluorescence staining
For the fluorescence visualization of loosely bound
synaptic (vesicular) and free zinc ions the dorsal
part of the left hemisphere was frozen and sections
(30 mm) were cut from the ventral surface of the
tissue block. The sections were thawed stained with
N-(6-methoxy-8-quinolyl)-para-toluenesulfonamide
TSQ by immersing the sections in a solution of TSQ
(4.5 mM) and 140 mM sodium barbital and 140 mM
sodium acetate buffer for 60 s, rinsed for 1 min,
in normal saline (NaCl, 0.9%), then viewed and
imaged using a compound Olympus fluorescence
microscope (UV filter: excitation, 330—385 nm; bar-
rier, 420 nm).32
I.c.v. route control experiment
Methyline blue was injected for i.c.v. route control.
Two hours after the injection animals (n = 2) were
decapitated under the isoflurane anesthesia. Lat-
eral ventricles were examinated, light microscopi-
cally.
Statistical analysis
All observations are given as means  S.E.M. Statis-
tical differences of the results were performed using
the analysis of variance (ANOVA) and p < 0.05 con-
sidered significant.Results
Behavioral evaluation of i.c.v. drug
injection and seizure activity
The latency and activity of seizures scores in the
different groups of rats receiving pilocarpine HCl are
summarized in Table 1. Rats, not injected with
pilocarpine HCl, behaved normally while rats
receiving an i.p. pilocarpine HCl injection all
showed signs of seizure activity. None of the animals
were lost because of having seizures for 2 h end of
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Table 1 Mean values of seizure latency and seizure scores at the pilocarpine (380 mg/kg i.p.) injected animals given
L-NAME (150 mg/10 ml), CaEDTA (100 mM/10 ml) or L-NAME (150 mg/10 ml) and CaEDTA (100 mM/10 ml)
Groups Seizure latency (min)
(mean  S.E.)
Seizure scores (point)
(mean  S.E.)
Seizure Control group (n = 10) 36.5  2.8 3.7  0.1
L-NAME group (n = 10) 38.2  1.9 3.6  0.3
CaEDTA group (n = 10) 35.3  2.4 3.7  0.1
L-NAME + CaEDTA Group (n = 10) 36.3  2.3 3.7  0.2
No significant differences were found in both seizure latency and seizure scores between the pilocarpine injected groups.which they were decapitated. No differences in the
average latency and intensity of seizure were found
between the seizure control group and the pilocar-
pine HCl injected animals receiving i.c.v. L-NAME,
CaEDTA or L-NAME and CaEDTA.
Immersion autometallography (iZnSAMG)
Samples of the immersion autometallography stain-
ing taken from all the experimental groups are
shown in Fig. 1. Although the immersion autome-
tallography staining intensity showed variation
between the samples obtained from different ani-
mals the distribution of histochemical stainable zinc
ions in hippocampus was indistinguishable between
the groups. The dentate hilus and the mossy fibers
were heavily stained whereas the stratum radiatum
in the CA1 and CA3 fields and the termination zone
of the perforant path showed less intense staining.
Also density measurements of the staining intensi-
ties in the mossy fibers termination zone and stra-
tum radiatum in area CA1 disclose no differenceFigure 1 (iZnSAMG) staining. Samples of the immersion aut
Dentate hilus (DH), mossy fibers (MF), Cornu ammonis (CA3) a
were found to stain normally (E—H, groups 5—8). It was not dif
groups (A—D, groups 1—4). Scale bar 500 mm.between the investigated groups (unpublished
data).
TSQ fluorescence staining
TSQ staining was used as an alternative to the
immersion autometallography methods to evaluate
the vesicular or free zinc staining pattern in hippo-
campus. Microscopic pictures of the TSQ fluores-
cence intensities in area CA1 and area CA3 were
compared between groups. In parallel with the
immersion autometallography staining no differ-
ences between pilocarpine injected groups and con-
trol groups could be detected. Samples obtained
from area CA3 of hippocampus are shown in Fig. 2.
The TSQ staining was used, furthermore, to evaluate
a possible seizure induced postsynaptic accumula-
tion of free zinc ions in the hippocampal pyramidal
cells. Despite careful inspection of more than five
samples from each animal we were unable to detect
any TSQ fluorescent positive nerve cell in area CA1
and CA3 of hippocampus.ometallography (iZnSAMG) staining taken from all groups.
nd Cornu ammonis (CA1) fields of the experimental groups
ferences between them and hippocampy from the control
414 B. Noyan et al.
Figure 2 TSQ staining. Samples of TSQ staining from mossy fibers (MF) and Cornu ammonis (CA3) area of all groups. Not
any difference was found among control groups (A—D, groups 1—4) and NOS inhibition or zinc chelation or where both
were performed and pilocarpine HCl injected groups (E—H, groups 5—8). Scale bar 100 mm.Control experiments
The results presented above could be explained by a
poor distribution of the injected pharmacological
substances in the ventricular system. In order to
control for this possibility methyline blue was
injected i.c.v. The dye showed an extensive distri-
bution in the ventricular system 2 h after the infu-
sion (Fig. 3). Furthermore, i.c.v. injection of the
benzodiazepine midazolam (0.1 mg/kg) promptly
arrested pilocarpine induced seizure activity. These
results indicate that the i.c.v. route of drug applica-
tion was functional.Figure 3 Methyline blue injection. Distribution of
methyline blue injection in the ventricular system. A
cannula was lowered 4—4.2 mm below the surface of
the skull and methyline blue was injected the left ven-
tricle. This result indicates that the intracerebroventri-
cular route for drug application was correct and
functional.Discussion
Our investigation show, as previously described,8
that i.c.v. injections of the NOS inhibitor L-NAME
in itself has no overt effects on animal behaviour.
Furthermore, injection of L-NAME did not affect the
latency or the intensity of seizures induced by pilo-
carpine. An increased production on NO which is
shown to be a feature of chemically induced epi-
leptic seizures34—36 may therefore not be a factor
which significantly affects initial excitability
changes caused by i.p. pilocarpine injections. In
support of this, the effects of NOS inhibition on
the initial phase of pilocarpine induced seizures is
known to be unpredictable. NOS inhibitors may be
anticonvulsive9,10 or be proconvulsive7,8 or be with-
out effects.11 Similar contradicting observations of
the effects of various NOS inhibitors have been
found in several other seizure models6 and the
effects of an increased NO production during pilo-
carpine induced seizures are complex too. In a
previous study we found that L-arginine (a nitric
oxide substrate) at a dose of 300 mg/kg acted as
an anticonvulsant in the litium-pilocarpine induced
seizure model.33
It has been shown that chelation of the intrave-
sicular pool of zinc by diethyldithiocarbamate is
associated with increased seizure susceptibility.37
Knock-out mice with a disruption of the gene encod-
ing for the vesicular zinc transporter ZnT3 have a
reduced convulsion threshold27 and mice lacking
zinc-binding proteins metallothioneins are also
more susceptible to kainic acid-induced seizures.38
The activity dependent increase in extracellular
zinc ions is therefore believed to be anticonvulsive.
This could be mediated by a direct attenuation of
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of glutamate release caused by activation of pre-
synaptic ATP sensitive potassium channels.39
I.c.v. injection of the zinc chelator CaEDTA had in
this study no effects on the initial phase of seizures
induced by pilocarpine and animal behavior. The
present experiments suggest therefore that zinc
ions chelatable by CaEDTA do not attenuate acute
pilocarpine seizures. Similarly, Lee et al.29 showed
in ZnT3-null mice that i.c.v. injection of CaEDTAwas
without effects on kainate induced seizure the first
2 h after kainate injection. The effect of zinc ions
chelation may therefore depend on the seizure
model and seizure time investigated. The acute
epileptogenic effect of pilocarpine is suggested to
be mediated mainly by M1 muscarinic receptors40,41
and depends on a much lesser degree on NMDA-
receptor operated mechanims. In support of the
latter it is known that the NMDA-receptor antagonist
MK-801 (dizocilpine) is inefficient in blocking
acutely induced pilocarpine seizures42 andmay even
sensitize rats to pilocarpine.8,43
It is suggested that the release of zinc ions stored
in synaptic vesicles and the translocation of these
ions to the postsynaptic compartment may trigger a
degeneration of nerve cells following brain insults
such as epilepsy,25 ischemia44 and traumatic brain
injury.45 Resent results obtained by using gene
knock-out mice lacking the vesicular zinc transpor-
ter ZnT3 have called for a modification of this
hypothesis.27,28 Accumulation of intracellular zinc
ions and degeneration of neurons following kainate
induced seizures occurs despite the fact that these
mice have no zinc ions in their glutamate containing
vesicles.27,29 Specific for the investigated model,
Suh et al.46 showed that pilocarpine induced sei-
zures was accompanied by a decrease in the TSQ
staining of themossy fibers and that accumulation of
zinc in pyramidal cell somatas could be detected
24 h later. In our study seizure activity arose 30 min
after the pilocarpine injection and lasted about
1.5 h. The seizures score on the Racine scale (3—
4) suggest that the seizures involved limbic struc-
tures including hippocampus,30 but the normal
immersion autometallography and TSQ staining pat-
tern was not affected by the seizures. This suggests
that a reduction of vesicular zinc and the appear-
ance of TSQ stainable zinc ions in pyramidal cells
may not be a feature of acute short time seizures
induced by pilocarpine. In accordance with this a
reduced TSQ staining of the mossy fiber boutons
could not be detected until 3 h after kainate injec-
tion.30,47
Finally, our study does not support the idea that
NOmediated release of zinc ions14,15 is an important
feature of pilocarpine induced seizures. Injection ofthe NOS inhibitor L-NAME in control rats or in rats
injected with pilocarpine induces seizures did not
affect the intensity or pattern of the iZnSAMG or the
TSQ staining in hippocampus. These results have to
be interpreted with some cautions because the
seizure activity induced by pilocarpine in itself
did not affect the zinc distribution in hippocampus.
In conclusion NOS inhibition, extracellular zinc
chelation or application of both at the same time do
not affect seizures and do not result in any detect-
able change of the histochemical distribution of zinc
ions in rats decapitated 2 h after a pilocarpine
injection. Therefore, NO production and zinc ion
release does not seem to be important epilepto-
genic factors in the early stage (2 h) of seizures
induced by pilocarpine.Acknowledgments
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